← Evidence map

ArticleAntibody therapeutics2024

Correction to: A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39257439